ADHD UK Logo
ADHD UK Logo

Henry Shelford, CEO and Co-Founder of ADHD UK, was quoted in the article and provided background information.

The article reports that individuals with ADHD in the UK are spending significant amounts on private treatment and medication due to long NHS waiting times. In 2022, over 400,000 private prescriptions for ADHD medication were issued, reflecting a substantial increase from previous years. The high costs associated with private care have led to concerns about accessibility and the potential for exacerbating health inequalities. Experts emphasize the need for improved NHS services to ensure timely and equitable access to ADHD diagnosis and treatment.

You can read the full article here: https://www.bbc.com/news/articles/cx2kykr0m0no

Doctors in England told not to start new patients on ADHD drugs due to shortage